The Impact of CBT-i on CPAP Therapy Use and Drop Outs in OSAS Patients With Insomnia.

NCT ID: NCT04306835

Last Updated: 2020-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-22

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients follow the fully standard sleep test according to the normal procedure. This means that they undergo a polysomnography and fill in a questionnaire. If according to the questionnaire, there is insomnia, the patient also receives an intake interview to check whether this is indeed the case. If the patient has both disorders and meets the inclusion and exclusion criteria, they will be asked to sign the informed consent. If the patient agrees, the CPAP-therapy will be started as usual, simultaneously with CGT-i. The latter will last 7 weeks and will cover the following points: psycho-education, sleep restriction and sleep hygiene, cognition, relaxation and relapse prevention. Because of the design of this study (starting CGT-I as soon as possible after the diagnosis of OSAS) and the groups already planned for CBT-I, it is not possible for all participants to participate in group cognitive behavioral therapy, therefore individual sessions were provided for these participants. The patient comes for monitoring at set times.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia Obstructive Sleep Apnea Cognitive Behavioral Therapy Continuous Positive Airway Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CPAP + CBT-i

Patients treated simultaneously with CPAP for their OSAS and cognitive behavioral therapy for their insomnia.

Group Type ACTIVE_COMPARATOR

Cognitive behavioural therapy for insomnia

Intervention Type BEHAVIORAL

a technique for treating insomnia without medications

CPAP only

Patients suffering from OSAS and insomnia, but only treated with CPAP.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive behavioural therapy for insomnia

a technique for treating insomnia without medications

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients, male and female, with an OSAS diagnosed by full polysomnography and insomnia diagnosed by questionnaires.
* Age between 18 and 75 years
* Dutch as native language

Exclusion Criteria

* Patients younger than 18 years and older than 75 years
* Patients with a burn-out
* Patients with restless legs
* Pregnant woman
* Patients who work as shift workers
* Patients with severe psychiatric disorder
* Patients who take sleep medication, unless it can be reduced and stopped during cognitive behavior therapy
* Patients with daily alcohol abuse (men \> 3 drinks on any day or 14 per week, women \> 2 drinks on any day or 7 per week)
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Brussel

Jette, Brussels Capital, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jasper Molenberghs

Role: CONTACT

0494182014

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sonia De Weerdt

Role: primary

024773890

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

143201836242

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cognitive-Behavior Therapy for Insomnia
NCT00869934 COMPLETED PHASE4